Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Versus Multiple Visits Endodontic Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02947763
Recruitment Status : Completed
First Posted : October 28, 2016
Last Update Posted : July 12, 2019
Sponsor:
Information provided by (Responsible Party):
Safeya AbdelRahaman Hassan, Cairo University

Brief Summary:
Healing rate after single visit or multiple visit endodontic treatment using triple paste intracanal medicament will be assessed both clinically and radio-graphically for follow-up period up to one year

Condition or disease Intervention/treatment Phase
Periapical Periodontitis Drug: mixture of metronidazole, ciprofloxacin, and minocycline Phase 1

Detailed Description:
Patients with necrotic teeth with apical periodontitis will be selected according to the eligibility criteria and patients are then randomized to either single visit or multiple visit using triple paste intracanal medicament. Postoperative pain will then assessed using numerical rating scale after 1, 2, 3 and 7 days post-instrumentation. Radiographic healing will be assessed every 3 months up to one year.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 44 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Healing Rates After Single Versus Multiple Visits Endodontic Treatment of Necrotic Teeth With Apical Periodontitis: A Randomized Clinical Trial
Actual Study Start Date : November 2016
Actual Primary Completion Date : January 2018
Actual Study Completion Date : February 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: multiple visit
multiple visit root canal treatment with triple antibiotic paste intracanal medication (a mixture of metronidazole, ciprofloxacin, and minocycline)
Drug: mixture of metronidazole, ciprofloxacin, and minocycline
placement of intracanal medication
Other Name: no other names

No Intervention: single visit
single visit root canal treatment without any intra-canal medication



Primary Outcome Measures :
  1. postoperative pain [ Time Frame: 24 hours ]
    using numerical rating scale from 0-10

  2. postoperative pain [ Time Frame: 48 hours ]
    using numerical rating scale from 0-10

  3. postoperative pain [ Time Frame: 72 hours ]
    using numerical rating scale from 0-10

  4. postoperative pain [ Time Frame: 7 days ]
    using numerical rating scale from 0-10


Secondary Outcome Measures :
  1. Radiographic healing [ Time Frame: 3 months ]
    using digital radiography

  2. Radiographic healing [ Time Frame: 6 months ]
    using digital radiography

  3. Radiographic healing [ Time Frame: 9 months ]
    using digital radiography

  4. Radiographic healing [ Time Frame: 12 months ]
    using digital radiography



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years to 55 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Adult patients; age between 16-55 years old.
  2. Males or Females.
  3. Maxillary or mandibular single-root tooth or a multi-rooted tooth with:

    • Non-vital response of pulp tissue.
    • Radiographic evidence of periapical lesions (minimum size 2.0 mm × 2.0 mm) related to one root in case of multi-rooted teeth.
    • Asymptomatic patients.
  4. Positive patients' acceptance for participation in the study.

Exclusion Criteria:

  1. Primary teeth, and permanent teeth with immature apex.
  2. Teeth previously accessed or endodontically treated.
  3. Patients with diabetes and immune-compromising disease.
  4. Patients allergic to metronidazole, ciprofloxacin, or minocycline.
  5. Vital cases or necrotic without periapical lesion.
  6. Pregnant women.
  7. Teeth with unfavorable conditions for rubber-dam application.
  8. Tooth associated with vertical root fracture, coronal perforation, calcification and external or internal root resorption.
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Safeya AbdelRahaman Hassan, Assistant lecturer, Cairo University
ClinicalTrials.gov Identifier: NCT02947763    
Other Study ID Numbers: CEBD-CU-2016-10-231
First Posted: October 28, 2016    Key Record Dates
Last Update Posted: July 12, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Periodontitis
Periapical Periodontitis
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases
Periapical Diseases
Jaw Diseases
Metronidazole
Ciprofloxacin
Minocycline
Anti-Infective Agents
Anti-Bacterial Agents
Antiprotozoal Agents
Antiparasitic Agents
Topoisomerase II Inhibitors
Topoisomerase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Cytochrome P-450 CYP1A2 Inhibitors
Cytochrome P-450 Enzyme Inhibitors